Date and time: May 4, 2023 between 12:00-16:00.
Place: Lecture hall 2, Biomedicum 1, Helsinki.
Format: hybrid (on site or remotely)
Registration ends: on site registration is now closed, but you can still register to participate remotely by May 2 [Registration link]
Link to online broadcast (Zoom) will be provided to registered participants a few days prior to the event.
12:00 Welcome and introduction.
Prof. Päivi Tammela, University of Helsinki
12:15 Drug sensitivity and resistance testing and chemical compound libraries at FIMM.
Dr. Sergey Kuznetsov. FIMM High Throughput Biomedicine Unit, University of Helsinki
12:35 DDCB services at the Faculty of Pharmacy
Prof. Arto Urtti. Faculty of Pharmacy, University of Helsinki
12:55 Services for Drug Discovery and Chemical Biology at Biocity Turku.
Dr. Michael Courtney, Turku Bioscience Centre, University of Turku and Åbo Academy University
13:15 Drug Discovery Services at University of Eastern Finland
Prof. Antti Poso. Molecular Modeling and Drug Design laboratory at University of Eastern Finland (Kuopio)
13:35 CSC's services for DDCB community.
Laxman Yetukuri, CSC – IT CENTER FOR SCIENCE LTD.
13:55 Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Dr. Mika Kontro, Helsinki University Hospital (HUS) and Institute for Molecular Medicine Finland (FIMM)
14:20 Screening for anti-virulence targets in multidrug resistant Pseudomonas aeruginosa & Acinetobacter baumannii.
Dr. Christopher Jonkergouw, Arivin Therapeutics and Aalto University
14:45 - 16:00 Mingle and network. Coffee and biscuit will be served.